Brief: Molecure Receives Positive IDMC Recommendation for KITE Trial
03/08/2026 17:05
BRIEF-Molecure Receives Positive IDMC Recommendation for KITE Trial Aug 3 (Reuters) - Molecure SA MOCP.WA:
RECEIVES POSITIVE IDMC RECOMMENDATION TO CONTINUE THE KITE CLINICAL TRIAL WITHOUT CHANGES TO THE STUDY PROTOCOL (OATD-01 DEVELOPMENT PROGRAM)
Source text: ID:nGNE7967Cz
Further company coverage: MOCP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure H1 Net Loss At 6.3 Million Zlotys
Brief: Molecure Receives Positive IDMC Recommendation for KITE Trial
Brief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr